JPRN-jRCT1041200085招募中3 期
Analysis of Liposomal irinotecan's pharmacokinetics and side effects
ANDO Yuichi0 个研究点目标入组 15 人开始时间: 2020年12月25日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Pancreatic cancer, underwent UGT1A1 polymorphism test
排除标准
- •Already used Onivyde(Liposomal irinotecan)
研究者
相似试验
招募中
2 期
Liposomal Irinotecan and Apatinib in ES-SCLCSmall Cell Lung Cancer Extensive StageNCT06749691Second Affiliated Hospital, School of Medicine, Zhejiang University30
招募中
4 期
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung CancerSmall Cell Lung CancerNCT06467786Tang-Du Hospital24
尚未招募
1 期
Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid TumorsSolid Tumor CancerNCT06710821Yizhuo Zhang40
进行中（未招募）
1 期
Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary CancerMetastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction AdenocarcinomaMetastatic Malignant Digestive System NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Colorectal Cancer AJCC v7Stage IV Pancreatic Cancer AJCC v6 and v7Stage IVA Colorectal Cancer AJCC v7Stage IVB Colorectal Cancer AJCC v7NCT03337087Academic and Community Cancer Research United18
已完成
1 期
Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid TumorsAdvanced Solid TumorNCT04088604Luye Pharma Group Ltd.38